Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
20.81B | 20.44B | 20.50B | 20.69B | 21.11B | 20.84B | Gross Profit |
14.03B | 14.34B | 14.28B | 14.25B | 13.99B | 13.02B | EBIT |
11.67B | 11.24B | 11.55B | 8.53B | 11.56B | 10.87B | EBITDA |
6.13B | 15.07B | 12.35B | 12.53B | 12.16B | 11.75B | Net Income Common Stockholders |
1.74B | 11.26B | 8.13B | 5.76B | 2.48B | 4.47B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.13B | 3.13B | 3.69B | 4.03B | 4.54B | 4.95B | Total Assets |
35.18B | 35.18B | 38.57B | 36.95B | 39.52B | 47.41B | Total Debt |
24.93B | 24.93B | 26.23B | 26.68B | 28.04B | 29.47B | Net Debt |
21.80B | 21.80B | 22.55B | 22.65B | 23.50B | 24.53B | Total Liabilities |
37.37B | 37.37B | 42.06B | 40.88B | 41.13B | 44.49B | Stockholders Equity |
-2.24B | -2.24B | -3.54B | -3.97B | -1.61B | 2.84B |
Cash Flow | Free Cash Flow | ||||
8.09B | 8.61B | 9.09B | 8.05B | 8.24B | 8.15B | Operating Cash Flow |
8.29B | 8.75B | 9.29B | 8.26B | 8.40B | 8.38B | Investing Cash Flow |
1.07B | 2.17B | -1.28B | 782.00M | 1.21B | -143.00M | Financing Cash Flow |
-8.65B | -11.49B | -8.37B | -9.54B | -10.03B | -5.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $29.66B | 9.36 | 45.38% | 5.26% | 5.61% | 23.39% | |
72 Outperform | $98.31B | 8.89 | -503.31% | 6.88% | -0.28% | 43.51% | |
67 Neutral | $236.49B | 33.65 | -37142.11% | 3.48% | 7.75% | -9.85% | |
64 Neutral | $2.90B | 31.93 | 4.04% | 0.35% | 110.63% | 693.33% | |
63 Neutral | $20.77B | 13.59 | -10.67% | 7.41% | 1.48% | 9.07% | |
62 Neutral | $1.34B | 10.91 | 8.32% | 5.95% | 12.88% | -6.33% | |
61 Neutral | $89.85B | 23.48 | 5.87% | 7.17% | -2.51% | ― |
On January 29, 2025, Altria’s Board of Directors elected Richard S. Stoddart as an independent director, effective February 3, 2025, and authorized a new $1 billion share repurchase program. The company reported strong financial results for 2024, including significant cash returns to shareholders and announced guidance for 2025 earnings, while facing challenges in the e-vapor market due to the proliferation of illicit products.